Healthcare companies are returning COVID-19 relief funds

Amy Baxter | | Health Exec | COVID-19
Money

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

These companies each received millions in funding and were among 500,000 providers who received the first chunk of relief funds, Business Insider reported. The Trump administration sent out $30 billion directly to companies that had recently billed Medicare to get relief out there quickly, and health agencies eventually released guidance on how healthcare agencies could accept the funding.

CVS Health previously announced it was returning $43 million in federal aid that it had received as part of the CARES Act Provider Relief Fund.

Encompass, a provider that specializes in home-based care, said it won’t accept the $237 million it received. Cigna, one of the nation’s largest health insurance companies, is returning $41 million in federal funds from its Accredo business. DaVita, even while facing losses, is returning $240 million in relief funds.

See the full story below:

Giant companies like CVS, DaVita, Walmart, and Cigna are returning coronavirus …

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Nursing home sued after horrific wound found on dementia patient
Walgreens resolves $595M lawsuit over COVID testing
Data trove of 1.6M patient records discovered online
DEA wants to permanently anchor some COVID-era prescription regulations
Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.